Dimethyl L-glutamate
Dimethyl L-glutamate (Dimethyl glutamate) is a NMDA receptor ligand and a cell membrane-permeable glutamate precursor. Dimethyl L-glutamate binds to NMDA receptors to regulate osteoblast maturation, and promotes osteoblast proliferation, adhesion, extracellular calcium deposition, and alkaline phosphatase activity. Dimethyl L-glutamate replenishes the glutamate pool in insulin-secreting β cells. Dimethyl L-glutamate can be used in research related to bone defects and non-insulin-dependent diabetes mellitus.
For research use only. We do not sell to patients.
- CAS No.: 6525-53-7
- Formula: C7H13NO4
- Molecular Weight:175.18
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All iGluR Isoforms
More
Biological Activity
Description
|
NMDA Receptor |
In Vitro
Dimethyl L-glutamate (Dimethyl glutamate) (20-100 μg/mL; overnight, 2 h) enhances protein adsorption on chitosan/microfibrillated cellulose-based composite scaffolds (S1-S7) in a concentration-dependent manner, with the highest adsorption at 20 μg/mL and optimal performance on S7 scaffolds[1].
Dimethyl L-glutamate (50-100 μg/mL; 1-7 days) treated chitosan/microfibrillated cellulose-based composite scaffolds (S1-S7) enhance MG63 cell viability in a time-dependent manner[1].
Dimethyl L-glutamate (50-100 μg/mL; 7 days) treated chitosan/microfibrillated cellulose-based composite scaffolds (S1-S7) enhance early-stage osteogenic differentiation of MG63 cells[1].
Dimethyl L-glutamate (50-100 μg/mL; 7 days) treated chitosan/microfibrillated cellulose-based composite scaffolds (S1-S7) enhance late-stage osteogenic differentiation of MG63 cells[1].
Dimethyl L-glutamate (5 mM) fully restores Glucose (D-Glucose) (HY-B0389)-stimulated insulin secretion in GC1-silenced INS-1E β-cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human osteoblast-like MG63 cells
-
Concentration:50-100 μg/mL (scaffold loading)
-
Incubation Time:1, 3, 5, 7 days (cell culture)
-
Result:Increased with longer culture duration across all scaffolds and concentrations.
Was higher on all treated scaffolds than untreated controls.
Chemical Information
-
CAS No. 6525-53-7
-
Molecular Weight 175.18
-
Formula C7H13NO4
-
Synonyms
Dimethyl glutamate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)